Today's Date: March 28, 2024
Modern Health & Naomi Osaka’s Hana Kuma Launch Mental Health Focused Video Podcast Series “Can’t Wait To H   •   Black & Veatch Distributed Infrastructure Business Awarded Highest OSHA Star Recognition   •   THE ST. JAMES AND TPH ACADEMY PARTNER TO LAUNCH PREMIER ACADEMIC AND SPORTS PERFORMANCE ACADEMY SERVING THE GREATER WASHINGTON R   •   Jack Link’s® Unveils a Sweet Collaboration with Dr Pepper® That Brings Two Classic Tastes Together   •   Yamaha Motor Signs Technical Partnership with Lola Cars for Development and Supply of Powertrains for Formula E   •   Intown Stars Sports Training and Events Center Wins Georgia Business Journal's 'Best of Georgia' and Atlanta Magazine's 'Best of   •   From Tee to Triumph: Teen Entrepreneur and Golf Sensation Hosts First Annual Autism Awareness Golf Tournament   •   Stamp showcasing maamoul commemorates Islamic festivals of Eid al-Fitr and Eid al-Adha   •   ComPsych Corporation Announces 2023 Health at Work Award Winners   •   Leading In-Home Care Franchise Looks to Expand in La Crosse   •   Lutheran Senior Services and Diakon Enter Into Senior Living Agreement   •   Boston Children’s Hospital and NRG Energy celebrate $1 million milestone, thanks to the Choose to Give program   •   /R E M I N D E R -- Travelling for Easter? The Canada Border Services Agency gives tips for a smooth trip/   •   Green Boom Expands Product Line to The Home Depot   •   Children's Hospital of Philadelphia's Richard D. Wood Jr. Center for Fetal Diagnosis and Treatment Earns Two Press Ganey Awards   •   Tractor Supply Opens Applications for Second Annual Open Buying Days Event   •   Guaranteed Rate Welcomes New Atlanta Branch Manager, Carlos Mata   •   Morningstar Publishes Fourth Annual Corporate Sustainability Report   •   The Religious Sub-forum of BFA 2024 to Feature the First Roundtable Thought Event   •   In 23rd Annual Sexual Assault Awareness Month Campaign, NSVRC Calls for Building Connected Communities to Prevent Sexual Violenc
Bookmark and Share

Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Sponsors Autism Event at Rice University in Houston

Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Sponsors Autism Event at Rice University in Houston

PR Newswire

SAN DIEGO, Feb. 25, 2020 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary HempMeds® Brasil, in partnership with the Consulate General of Brazil in Houston, sponsored "Autism Together We Are Stronger" at Rice University on February 22.

"We see events like this one as prime opportunities to educate people on what cannabidiol, or CBD, is and its potential benefits," said HempMeds® Brasil Vice President Caroline Heinz. "CBD can be legally imported in Brazil and is even subsidized by the Brazilian government for many indications including autism. We want to do everything we can to help bring awareness to current research that is being conducted on how CBD can be used by people around the world."

In addition to sponsoring the event, HempMeds® Brasil shared the event stage with two researchers who the Company has worked with frequently in the past, Dr. Alysson Muotri, Professor at the School of Medicine, University of California in San Diego, and Dr. Abram Topczewski, Neuropediatrician and Enuresis Clinic Director at the Albert Einstein Hospital.

"Education is the most important thing when it comes to helping the world become more accepting of cannabis and its compounds," said Medical Marijuana, Inc. CEO Dr. Stuart Titus. "We're proud to be able to sponsor events like these and work with such prestigious doctors such as Dr. Muotri and Dr. Topczewski to help further medical research around the world."

To learn more about HempMeds® Brasil, please visit https://hempmedsbr.com/.

About HempMeds® Brasil 

HempMeds® Brasil was the first company to receive approval from the National Sanitary Surveillance Agency (Anvisa) to import a product based on cannabidiol, a substance derived from hemp, a plant of the genus Cannabis. Currently, it is authorized to supply its products, which help in the control of diseases such as epilepsy, Parkinson's, chronic pain and multiple sclerosis, under medical prescription. For these indications, the products can be subsidized by the Brazilian government. HempMeds® Brasil is working on additional approvals for other indications. www.hempmeds.com.br.

About Medical Marijuana, Inc.

We are a company of firsts®. Medical Marijuana, Inc. (MJNA) is a cannabis company with three distinct business units in the non-psychoactive cannabinoid space: a global portfolio of cannabinoid-based nutraceutical brands led by Kannaway® and HempMeds®; a pioneer in sourcing the highest-quality legal non-psychoactive cannabis products derived from industrial hemp; and a cannabinoid-based clinical research and botanical drug development sector led by its pharmaceutical investment companies and partners including AXIM® Biotechnologies, Inc. and Kannalife, Inc. Medical Marijuana, Inc. was named a top CBD producer by CNBC. Medical Marijuana, Inc. was also the first company to receive historic import permits for CBD products from the governments of Brazil, Mexico, Argentina, and Paraguay and is a leader in the development of international markets. The company's flagship product Real Scientific Hemp Oil has been used in several successful clinical studies throughout Mexico and Brazil to understand its safety and efficacy.

Medical Marijuana, Inc.'s headquarters is in San Diego, California, and additional information is available at OTCMarkets.com or by visiting www.medicalmarijuanainc.com. To see Medical Marijuana, Inc.'s corporate video, click here.

Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.'s shop.

FORWARD-LOOKING DISCLAIMER

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.

FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

LEGAL DISCLOSURE

Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act.

CONTACT:

Public Relations Contact:

Andrew Hard

Chief Executive Officer

CMW Media

P. 858-264-6600

andrew.hard@cmwmedia.com

www.cmwmedia.com

Investor Relations Contact:

P. (858) 283-4016

Investors@medicalmarijuanainc.com

 

Cision View original content:http://www.prnewswire.com/news-releases/medical-marijuana-inc-subsidiary-hempmeds-brasil-sponsors-autism-event-at-rice-university-in-houston-301010518.html

SOURCE Medical Marijuana, Inc.



Back to top
| Back to home page
Video

White House Live Stream
LIVE VIDEO EVERY SATURDAY
alsharpton Rev. Al Sharpton
9 to 11 am EST
jjackson Rev. Jesse Jackson
10 to noon CST


Video

LIVE BROADCASTS
Sounds Make the News ®
WAOK-Urban
Atlanta - WAOK-Urban
KPFA-Progressive
Berkley / San Francisco - KPFA-Progressive
WVON-Urban
Chicago - WVON-Urban
KJLH - Urban
Los Angeles - KJLH - Urban
WKDM-Mandarin Chinese
New York - WKDM-Mandarin Chinese
WADO-Spanish
New York - WADO-Spanish
WBAI - Progressive
New York - WBAI - Progressive
WOL-Urban
Washington - WOL-Urban

Listen to United Natiosns News